Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
$4,685,791N01FY2025AINIH
Eveliqure Biotechnologies, Gmbh, Veinna
Investigators
Abstract
To support the advanced development of a candidate vaccine for resistant bacteria. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation. This project includes a Phase 2 clinical trial.
View original record on NIH RePORTER →